Trial intelligence / Profile preview

Long-Term Exposure to Rizatriptan

NCT01286207Phase 3Completed

Sponsor
Organon & Co.
Start
Mar 1995
Primary completion
May 1997
Modality
Small Molecules
01

Overview

A Phase 3 trial of rizatriptan in migraine, sponsored by Organon & Co.. Started Mar 1995; status: completed.

02

Drugs

rizatriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01286207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01286207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call